AMBER GRABER: Open Payments
NPI 1649649781 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,281 in 163 payments from 20 companies in 2025. Trend: 2023 $981 · 2024 $1,322 · 2025 $2,281
Food & beverage: $2,281
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $473 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $452 |
| Axsome Therapeutics, Inc. | 24 | $277 |
| PFIZER INC. | 13 | $249 |
| Alkermes, Inc. | 11 | $177 |
| Otsuka America Pharmaceutical, Inc. | 9 | $155 |
| Lundbeck LLC | 16 | $147 |
| Indivior Inc. | 3 | $64 |
| Vanda Pharmaceuticals Inc. | 3 | $51 |
| GlaxoSmithKline, LLC. | 2 | $37 |
Products named: CAPLYTA, Auvelity, REXULTI, VRAYLAR, NURTEC ODT, ARISTADA, MAVYRET, QULIPTA.
Industry payments across IN — which companies pay providers there.
